Krystal Biotech Common Stock Payments (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

266.49 -8.10 (-2.95%) USD | NASDAQ | Feb 24, 15:18

View Common Stock Payments (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Common Stock Payments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Common Stock Payments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Common Stock Payments (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
DexCom, Inc.	--
Alkermes Plc	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	--